These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Is the measurement of inferior thyroid artery blood flow velocity by color-flow Doppler ultrasonography useful for differential diagnosis between gestational transient thyrotoxicosis and Graves' disease? A prospective study. Zuhur SS; Ozel A; Velet S; Buğdacı MS; Cil E; Altuntas Y Clinics (Sao Paulo); 2012; 67(2):125-9. PubMed ID: 22358236 [TBL] [Abstract][Full Text] [Related]
5. Evaluation of thyrotoxicosis during pregnancy with color flow Doppler sonography. Hari Kumar KV; Vamsikrishna P; Verma A; Muthukrishnan J; Meena U; Modi KD Int J Gynaecol Obstet; 2008 Aug; 102(2):152-5. PubMed ID: 18456267 [TBL] [Abstract][Full Text] [Related]
6. Serial in utero ultrasonographic measurements of the fetal thyroid: a new complementary tool in the management of maternal hyperthyroidism in pregnancy. Cohen O; Pinhas-Hamiel O; Sivan E; Dolitski M; Lipitz S; Achiron R Prenat Diagn; 2003 Sep; 23(9):740-2. PubMed ID: 12975785 [TBL] [Abstract][Full Text] [Related]
7. Diagnosis and successful in utero treatment of a fetal goitrous hyperthyroidism caused by maternal Graves' disease. A case report. Heckel S; Favre R; Schlienger JL; Soskin P Fetal Diagn Ther; 1997; 12(1):54-8. PubMed ID: 9101225 [TBL] [Abstract][Full Text] [Related]
8. Recurrent fetal thyrotoxicosis in a woman with Graves' disease: case report. Ting MK; Hsu BR; Huang YY; Lin JD; Chen TC Changgeng Yi Xue Za Zhi; 1999 Sep; 22(3):492-7. PubMed ID: 10584424 [TBL] [Abstract][Full Text] [Related]
9. The incidence of gestational hyperthyroidism and postpartum thyroiditis in treated patients with Graves' disease. Tagami T; Hagiwara H; Kimura T; Usui T; Shimatsu A; Naruse M Thyroid; 2007 Aug; 17(8):767-72. PubMed ID: 17651013 [TBL] [Abstract][Full Text] [Related]
10. Role of ultrasonography in the differential diagnosis of thyrotoxicosis: a noninvasive, cost-effective, and widely available but underutilized diagnostic tool. Alzahrani AS; Ceresini G; Aldasouqi SA Endocr Pract; 2012; 18(4):567-78. PubMed ID: 22440986 [TBL] [Abstract][Full Text] [Related]
11. Maternal Thyrotropin Receptor Antibody Concentration and the Risk of Fetal and Neonatal Thyrotoxicosis: A Systematic Review. van Dijk MM; Smits IH; Fliers E; Bisschop PH Thyroid; 2018 Feb; 28(2):257-264. PubMed ID: 29325496 [TBL] [Abstract][Full Text] [Related]
12. [Development of neonatal Graves' disease--prediction, prevention and treatment]. Matsuura N Nihon Rinsho; 2006 Dec; 64(12):2303-7. PubMed ID: 17154096 [TBL] [Abstract][Full Text] [Related]
13. Serial changes in thyroid-stimulating antibody and thyrotropin binding inhibitor immunoglobulin at the time of postpartum occurrence of thyrotoxicosis in Graves' disease. Tamaki H; Amino N; Aozasa M; Mori M; Tanizawa O; Miyai K J Clin Endocrinol Metab; 1987 Aug; 65(2):324-30. PubMed ID: 2885336 [TBL] [Abstract][Full Text] [Related]
14. Graves' disease and thymic hyperplasia: the relationship of thymic volume to thyroid function. Popoveniuc G; Sharma M; Devdhar M; Wexler JA; Carroll NM; Wartofsky L; Burman KD Thyroid; 2010 Sep; 20(9):1015-8. PubMed ID: 20718680 [TBL] [Abstract][Full Text] [Related]